Market Cap
$10.89B$7.53M+0.07%
Summary
- Current Value
- As of today, RNA market cap is $11B, up +0.07% in the current trading session
- Category
- Based on its current market cap, RNA falls into the large-cap category
- Historical Performance
- RNA market cap is up +0.24% year-to-date, and up +195.11% over the past 365 days
- All-Time High Comparison
- RNA market cap is currently -0.06% below its historical high of $11B set on
- 3-Year Low Comparison
- RNA market cap is +2918.75% above its 3-year low of $361M reached on
- Sector Comparison
- RNA market cap is higher than 91.62% of companies in Healthcare sector
Market Cap Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11B | +0.1% | +0.9% | +58.1% | +0.2% | +195.1% | +687.4% | +1045.2% | |
| Price | $72.30 | +0.1% | +0.9% | +54.0% | +0.2% | +134.8% | +264.6% | +185.6% | |
| Shares Outstanding | 150.68M | +2.6% | – | – | – | +25.7% | +116.0% | +301.1% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $20.87M | +94.5% | – | +94.5% | – | +106.3% | +151.2% | +242.7% | |
| TTM EPS | -$4.17 | -17.2% | – | -17.2% | – | -43.9% | -27.8% | -306.3% | |
| Enterprise Value | $9.07B | +0.1% | +1.1% | +79.0% | +0.3% | +312.8% | +1057.4% | +1353.1% | |
| - | – | – | – | – | – | – | – | ||
| TTM Net Income | -$549.79M | -20.6% | – | -20.6% | – | -96.0% | -239.2% | -1328.7% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $11B | -0.1% | |
| 3M | $11B | -0.1% | |
| 6M | $11B | -0.1% | |
| 1Y | $11B | -0.1% | |
| 3Y | $11B | -0.1% | |
| 5Y | $11B | -0.1% | |
| All | $11B | -0.1% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $11B | +1.5% | |
| 3M | $7B | +58.4% | |
| 6M | $3B | +213.2% | |
| 1Y | $3B | +275.4% | |
| 3Y | $361M | +2918.8% | |
| 5Y | $361M | +2918.8% | |
| All | $361M | +2918.8% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $11B | +0.2% | |
| $11B | +211.7% | |
| $3B | +386.0% | |
| $717M | -53.7% |
| Date | Value | Change |
|---|---|---|
| $2B | +36.4% | |
| $1B | +18.4% | |
| $959M | - |
FAQ
What is the current market cap of RNA?
As of today, RNA market cap is $11B
What market cap category does RNA fall into?
Based on its current market cap, RNA falls into the large-cap category
What is RNA market cap today change?
RNA market cap is up +0.07% today
What is 1-year change in RNA market cap?
RNA market cap is up +195.11% year-over-year
How far is RNA market cap from its all-time high?
RNA market cap is currently -0.06% below its historical high of $11B set on December 19, 2025
How does RNA market cap rank versus sector peers?
RNA market cap is higher than 91.62% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna